River Front Investment Group, LLC Edwards Lifesciences Corp Transaction History

River Front Investment Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$102.91 - $122.75 $295,042 - $351,924	-2,867 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $8,970 - $11,209	107 Added 3.88%	2,867 $297,000
Q1 2021 Apr 29, 2021	BUY	$78.68 - $90.67 $33,281 - $38,353	423 Added 18.1%	2,760 $230,000
Q4 2020 Feb 03, 2021	BUY	$71.69 - $91.23 $167,539 - $213,204	2,337 New	2,337 $213,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of River Front Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on River Front Investment Group, LLC with notifications on news.